Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled Arterial Protection to Ultimately Remove Embolic Material

NCT07276711 is registered in ClinicalTrials.gov with EmStop Inc as lead sponsor.

NCT NCT07276711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07276711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled Arterial Protection to Ultimately Remove Embolic Material
Lead sponsor
EmStop Inc
Phase
Not applicable
Overall status
Recruiting
Start date
May 12, 2026
Completion date
May 31, 2028
Enrollment
663 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, aortic valve disease, aortic valve stenosis